FR3045M - Médicament a base d'un nouveau dérivé de la phénothiazine. - Google Patents

Médicament a base d'un nouveau dérivé de la phénothiazine.

Info

Publication number
FR3045M
FR3045M FR950738A FR950738A FR3045M FR 3045 M FR3045 M FR 3045M FR 950738 A FR950738 A FR 950738A FR 950738 A FR950738 A FR 950738A FR 3045 M FR3045 M FR 3045M
Authority
FR
France
Prior art keywords
phenothiazine
product based
medicinal product
new derivative
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR950738A
Other languages
English (en)
Inventor
Jany Renz
Jean-Pierre Bourquin
Hans Winkler
Conrad Brueschweiler
Gustav Schwarb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH870962A external-priority patent/CH416636A/de
Priority claimed from CH870862A external-priority patent/CH415627A/de
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of FR3045M publication Critical patent/FR3045M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Preliminary Treatment Of Fibers (AREA)
FR950738A 1962-07-19 1963-10-16 Médicament a base d'un nouveau dérivé de la phénothiazine. Expired FR3045M (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH870962A CH416636A (de) 1962-07-19 1962-07-19 Verfahren zur Herstellung neuer heterocyclischer Verbindungen
CH870862A CH415627A (de) 1962-07-19 1962-07-19 Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
CH1240762 1962-10-23
CH1240862 1962-10-23
FR941800A FR1363683A (fr) 1962-07-19 1963-07-17 Nouveaux dérivés de la phénothiazine et leur préparation

Publications (1)

Publication Number Publication Date
FR3045M true FR3045M (fr) 1965-01-04

Family

ID=27429170

Family Applications (2)

Application Number Title Priority Date Filing Date
FR941800A Expired FR1363683A (fr) 1962-07-19 1963-07-17 Nouveaux dérivés de la phénothiazine et leur préparation
FR950738A Expired FR3045M (fr) 1962-07-19 1963-10-16 Médicament a base d'un nouveau dérivé de la phénothiazine.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR941800A Expired FR1363683A (fr) 1962-07-19 1963-07-17 Nouveaux dérivés de la phénothiazine et leur préparation

Country Status (15)

Country Link
US (1) US3314948A (fr)
BE (1) BE635096A (fr)
BR (1) BR6350873D0 (fr)
DE (2) DE1246742B (fr)
DK (2) DK117771B (fr)
ES (1) ES290082A1 (fr)
FI (1) FI42086B (fr)
FR (2) FR1363683A (fr)
GB (2) GB1043852A (fr)
LU (1) LU44067A1 (fr)
MY (1) MY6900114A (fr)
NL (3) NL6608685A (fr)
NO (2) NO119637B (fr)
OA (1) OA00707A (fr)
SE (2) SE318568B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452531A (de) * 1964-10-09 1968-03-15 Sandoz Ag Verfahren zur Herstellung von neuen Thieno-benzothiazin-Derivaten
FR2497806A1 (fr) * 1981-01-13 1982-07-16 Pharmindustrie Nouveau procede de preparation du n,n-dimethyl (aza-1 bicyclo (2,2,2) octyl-3)-10 10h-phenothiazinesulfonamide-2
USD901671S1 (en) 2018-11-28 2020-11-10 Rpc Formatec Gmbh Inhaler

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556474A (fr) * 1956-04-07 1960-02-26 Rhone Poulenc Sa Nouveaux derives de la phenothiazine et leur preparation.
NL97976C (fr) * 1956-04-07 Krupp Ag
CH365379A (de) * 1956-04-18 1962-11-15 Sandoz Ag Verfahren zur Herstellung von neuen, in 3-Stellung mit einer einwertigen Schwefelfunktion substituierten Phenothiazinen
NL123928C (fr) * 1960-03-10 1900-01-01

Also Published As

Publication number Publication date
OA00707A (fr) 1967-07-15
DE1246742B (de) 1967-08-10
BE635096A (fr)
NO119637B (fr) 1970-06-15
NO123346B (fr) 1971-11-01
DK111617B (da) 1968-09-23
ES290082A1 (es) 1963-10-16
SE324770B (fr) 1970-06-15
BR6350873D0 (pt) 1973-06-28
GB1043853A (en) 1966-09-28
NL123137C (fr)
FR1363683A (fr) 1964-06-12
DK117771B (da) 1970-06-01
DE1620242A1 (de) 1970-06-04
FI42086B (fr) 1970-02-02
NL6608685A (fr) 1966-08-25
MY6900114A (en) 1969-12-31
US3314948A (en) 1967-04-18
NL295220A (fr)
SE318568B (fr) 1969-12-15
GB1043852A (en) 1966-09-28
LU44067A1 (fr) 1964-01-16

Similar Documents

Publication Publication Date Title
FR3806M (fr) Médicament a base d'un dérivé de la quinazolone-(4).
FR3074M (fr) Médicament a base d'un nouveau dérivé hétérocyclique du benzocycloheptane.
FR3348M (fr) Médicament a base d'un nouveau dérivé de la 5.6-dihydromorphanthridine.
FR3148M (fr) Médicament a base d'un nouveau dérivé de la 5.6-dihydromorphanthridine.
FR2186M (fr) Médicament a base d'un dérivé de l'aniline.
FR3405M (fr) Médicament a base d'une sulfométhyl-polymyxine.
FR2094M (fr) Médicament a base d'un nouvel hendécapeptide.
FR3045M (fr) Médicament a base d'un nouveau dérivé de la phénothiazine.
FR3680M (fr) Médicament a base d'un nouveau dérivé du thiaxanthe?
FR3101M (fr) Médicament a base d'un nouveau composé aryl-tétralylique.
FR2869M (fr) Médicament a base d'un dérivé de la cymarine.
FR3040M (fr) Médicament a base de dérivés basiques du dibenzo-cycloheptane.
FR3586M (fr) Médicament a base de dérivé de diméthyl xanthine.
FR1891M (fr) Médicament a base d'un phénoxy-alcane.
FR1843M (fr) Médicament a base d'amides d'acides 1.4-benzodioxanne-carboxyliques.
FR3351M (fr) Médicament a base d'un nouveau dérivé de la 1.2-diphényl-3.5-dioxo-pyrazolidine.
FR3799M (fr) Médicament a base d'un nouveau dérivé de la phénothiazine.
FR3778M (fr) Médicament a base d'un nouveau dérivé de thiophene.
FR3649M (fr) Médicament a base d'un nouveau dérivé de l'indole.
FR3078M (fr) Médicament a base d'un nouveau polypeptide.
FR3798M (fr) Médicament a base d'un nouveau dérivé de l'anthracene.
FR3323M (fr) Médicament a base de dérivé de l'aza-thiaxanthene.
FR2904M (fr) Médicament a base d'un nouveau polypeptide.
FR3223M (fr) Médicament a base d'un dérivé du dihydro-anthracene.
FR1264M (fr) Médicament a base d'un dérivé de la phénothiazine.